ANXA1 and obesity due to melanocortin 4 receptor deficiency: Higher levels of cleaved ANXA1 are observed in obesity, which may mediate its anti-inflammatory and pro-resolving actions locally, thus, ANXA1 may have an important pathophysiological mechanism involved in the inflammatory status observed in obesity [18].